FPV Ventures

FPV Ventures is a venture capital investment firm based in San Francisco, California, founded in 2022. Specializing in early-stage companies, the firm focuses on identifying and supporting innovative startups across various sectors. As a Registered Investment Adviser, FPV Ventures is committed to providing strategic guidance and financial resources to help its portfolio companies grow and succeed in a competitive market.

Pegah Ebrahimi

Co-Founder and Managing Partner

29 past transactions

Edera

Series A in 2025
Edera is a cybersecurity company that specializes in robust workload isolation solutions for Kubernetes and AI environments. Its core technology, a cloud-native Type 1 hypervisor, ensures each container operates within its own isolated kernel, preventing lateral movement and eliminating container escapes. This approach enhances security without compromising performance. Edera's platform is designed for seamless integration, requiring minimal configuration to secure workloads across various infrastructures. Additionally, the company supports open-source initiatives, such as 'Am I Isolated,' a Rust-based container runtime scanner that detects gaps in container isolation.

Enveda Biosciences

Series C in 2024
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Edera

Seed Round in 2024
Edera is a cybersecurity company that specializes in robust workload isolation solutions for Kubernetes and AI environments. Its core technology, a cloud-native Type 1 hypervisor, ensures each container operates within its own isolated kernel, preventing lateral movement and eliminating container escapes. This approach enhances security without compromising performance. Edera's platform is designed for seamless integration, requiring minimal configuration to secure workloads across various infrastructures. Additionally, the company supports open-source initiatives, such as 'Am I Isolated,' a Rust-based container runtime scanner that detects gaps in container isolation.

Credo AI

Series B in 2024
Credo AI is focused on enabling enterprises to responsibly develop, adopt, and utilize artificial intelligence at scale. The company offers an AI governance platform that automates oversight and risk management, ensuring compliance with emerging global standards such as the EU AI Act and NIST. Founded in 2020, Credo AI's platform supports organizations in measuring, monitoring, and managing risks associated with AI, which helps build customer trust and unlock sales opportunities. By prioritizing human control over AI technologies, Credo AI aims to enhance both business outcomes and societal benefits. The company has received recognition in the industry, including listings in CBInsights AI 100 and accolades from the World Economic Forum and Fast Company.

Vectara

Series A in 2024
Vectara is a provider of a generative AI product platform that enables the integration of advanced AI features into various applications. Its offering includes a serverless Retrieval Augmented Generation (RAG) API platform designed to embed generative AI functionality into chatbots and other products, relying on a robust hybrid-search core. This platform ensures accurate and contextually relevant responses, addressing critical challenges for enterprise adoption such as reducing hallucination, enhancing explainability, enforcing access control, and allowing real-time updates of knowledge. Vectara's technology also emphasizes data security and supports multilingual capabilities, making it suitable for a broad range of applications including conversational AI, question-answering, and semantic search. Through its innovative platform, Vectara helps businesses create effective AI-driven experiences while maintaining compliance with intellectual property and bias considerations.

Formation Bio

Series D in 2024
Formation Bio is a biotechnology company dedicated to accelerating drug development and enhancing patient access to new treatments by reimagining clinical trials. The company has developed a platform that scales a network of clinical trial sites integrated within existing medical practices. By utilizing a roaming cohort of certified research coordinators and leveraging advanced software and data analytics, Formation Bio enables researchers to optimize their access to human subjects for various studies, including clinical trials and psychological research. This innovative approach aims to streamline the clinical trial process, ultimately facilitating faster delivery of new therapies to patients.

Enveda Biosciences

Series B in 2024
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Astra

Series A in 2024
Astra, established in 2016 and based in Menlo Park, California, specializes in budgeting automation. Its platform connects to users' bank accounts, providing personalized financial recommendations and enabling automated money transfers or notifications based on user-defined rules and triggers.

HumanX

Seed Round in 2024
HumanX focuses on AI serves as a catalyst for enterprises to identify realistic solutions in the rapidly changing AI field.

Reken

Seed Round in 2024
Reken is an AI and cybersecurity company established in 2024 and headquartered in San Francisco, California. The firm focuses on developing an innovative platform designed to address threats posed by generative artificial intelligence, including deepfake social engineering and automated fraud. Reken's approach combines a layered defense strategy with elements of zero trust, allowing for comprehensive technological analysis of content to help users effectively identify malicious activities. By creating a new category of AI products, Reken aims to enhance security measures against evolving AI-enabled threats.

Charlie

Series A in 2023
Charlie is the new standard for 62+ banking* services. Charlie helps retirees make the most of their limited resources with features including faster access to their Social Security check, competitive earnings on deposits, no monthly fees or minimums, US-based customer service, and a simple, transparent digital experience designed for their needs. Charlie is transforming financial assistance for the 62+ community and providing peace of mind around their financial present and future. Charlie is not a bank, banking services provided by Sutton Bank; Member FDIC. To learn more, visit Charlie.com.

Charlie

Debt Financing in 2023
Charlie is the new standard for 62+ banking* services. Charlie helps retirees make the most of their limited resources with features including faster access to their Social Security check, competitive earnings on deposits, no monthly fees or minimums, US-based customer service, and a simple, transparent digital experience designed for their needs. Charlie is transforming financial assistance for the 62+ community and providing peace of mind around their financial present and future. Charlie is not a bank, banking services provided by Sutton Bank; Member FDIC. To learn more, visit Charlie.com.

Aibidia

Series A in 2023
Aibidia, established in 2018, offers a digital transfer pricing platform designed to enhance how multinational enterprises manage their cross-border business activities. The platform allows organizations to make informed transfer pricing decisions by shifting the focus from traditional document creation and data entry to value creation and actionable insights. With the capability to manage over 5,000 legal entities, Aibidia empowers its clients—who average 7 billion euros in revenue—to implement effective tax strategies and take control of their global operations. The company is committed to transforming the management of international business, facilitating healthier global business practices.

Enveda Biosciences

Series B in 2023
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Yendo

Series A in 2023
Yendo is a company that offers accounting software and asset-backed credit card solutions for small and medium-sized businesses and consumers. The accounting software, accessible via the cloud, allows users to manage various financial aspects including invoicing, expenses, and financial reporting, enabling them to track their company's performance effectively. Based in Ireland, Yendo serves a notable customer base in the United Kingdom and the United States. Additionally, the company provides credit cards secured by vehicles and homes, allowing consumers to leverage the equity in their assets for higher credit limits and lower interest rates compared to traditional bank-issued credit cards. This platform enables users to qualify for credit without the need for a FICO score check, making it accessible to a wider audience.

Fable

Series A in 2023
Fable Food Co is a company that specializes in creating plant-based meat alternatives primarily derived from shiitake mushrooms. Their products are designed to replicate the taste and texture of traditional meat, providing a nutritious and healthy substitute for consumers. Fable's offerings are clean label and minimally processed, made entirely from natural plant-based ingredients. The company's products are widely available across Australia, including major retailers such as Harris Farm Markets, Coles, and Woolworths, as well as through meal delivery services like Marley Spoon and Dinnerly. Additionally, Fable's products feature on various restaurant menus in Australia, Singapore, and the UK, catering to both food enthusiasts and those seeking vegan options.

Enveda Biosciences

Series B in 2022
Enveda Biosciences is a biotechnology company focused on drug discovery through the exploration of chemical diversity found in nature. Utilizing AI-powered tools, the company develops a robust database of chemical molecules derived from living organisms. Enveda's platform integrates machine learning, metabolomics, and robotics to analyze natural samples for their chemical structures and biological activities. This innovative approach allows for the efficient identification of potential new medicines, including antibiotics and hypotensives, without the need for isolating individual compounds or conducting extensive experiments. By harnessing nature's hidden chemistry, Enveda aims to accelerate the development of novel therapeutics for the healthcare industry.

Strand Therapeutics

Series A in 2022
Strand Therapeutics Inc. is a biotechnology company based in Boston, Massachusetts, founded in 2017. The company focuses on genetically programming mRNA to develop innovative therapies that enhance patient outcomes. Utilizing its mRNA programming technology, Strand Therapeutics creates gene therapies powered by synthetic biology, which include immunotherapies designed to stimulate cells to produce cancer-targeting proteins. This approach improves the immune system's ability to combat cancer by enabling precise control over the timing, location, and intensity of therapeutic protein expression. The technology leverages cell-type specific expression and responds to specific molecular signals, allowing for tailored therapeutic interventions.

Galileo

Series A in 2022
Galileo.ai is an AI platform that specializes in developing, testing, monitoring, and securing AI applications. It offers a data intelligence platform that enhances machine learning by analyzing unlabeled data to automatically identify error patterns and data gaps within models. This capability allows clients to improve operational efficiencies, reduce costs, and address data biases across various sectors, including healthcare, financial services, and insurance. Through its innovative solutions, Galileo.ai aims to advance the effectiveness of AI technologies in diverse industries.

LatticeFlow

Series A in 2022
LatticeFlow is a developer of system management software focused on assisting organizations in building and deploying artificial intelligence models that are safe, reliable, and trustworthy. The company's software includes a core programming API that supports a new asynchronous data coordination framework, which is essential for testing and certifying AI systems. This framework ensures that machine learning models function as intended and are prepared for production use. By providing these tools, LatticeFlow enables clients to efficiently integrate AI models into their operations, fostering greater understanding and trust in AI technologies.

Astra

Series A in 2022
Astra, established in 2016 and based in Menlo Park, California, specializes in budgeting automation. Its platform connects to users' bank accounts, providing personalized financial recommendations and enabling automated money transfers or notifications based on user-defined rules and triggers.

Oneleet

Venture Round in 2022
Oneleet is a cybersecurity company that offers a comprehensive platform aimed at helping businesses prevent cyber attacks. The platform combines artificial intelligence with expert manual security testing, providing a service that includes both automated and manual assessments. It features tools such as a web asset scanner and a compliance checker, allowing organizations to seamlessly incorporate security testing into their cybersecurity processes. By leveraging vetted expert penetration testers, Oneleet delivers scalable manual cybersecurity testing as a service, ensuring that businesses can effectively address their security needs.

X1

Series B in 2022
X1 is a financial services company that offers an innovative credit card designed to enhance the shopping experience. The X1 Card is crafted from stainless steel and features advanced technology that allows for smart credit limits and an attractive rewards program. Cardholders can earn points for every purchase, which can be redeemed for various benefits. The card is backed by Visa Signature, giving users access to over 46 million merchants globally. Co-founded by former Twitter employees Deepak Rao and Siddharth Batra, X1 has attracted notable investors, including PayPal co-founder Max Levchin and others with significant experience in technology and finance. Through its unique offerings, X1 aims to transform traditional credit card usage and improve the way consumers shop and spend.

Xilis

Series A in 2022
Xilis, Inc. is a biotechnology company based in Chapel Hill, North Carolina, founded in 2019. It specializes in developing advanced organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. The company's flagship platform, XilisµO, facilitates rapid diagnostics and personalized drug screening while providing scalable, patient-derived models for high-throughput drug discovery. This technology supports physicians and pharmaceutical companies in creating tailored treatments by enabling effective drug screening, ultimately contributing to more precise and cost-efficient cancer therapies.

Manifold Bio

Series A in 2022
Manifold Biotechnologies, Inc. is a biotechnology company that specializes in developing platforms for the pharmacological measurement of various therapeutic protein variants. By integrating DNA technologies with machine learning, the company aims to create protein drugs that address challenging diseases. Manifold Bio's innovative approach includes a protein barcoding platform designed to enable multiplexed quantitation of protein therapeutics, thereby generating extensive data that enhances the drug development process. Founded in 2019 and located in Allston, Massachusetts, the company is focused on advancing measurement-driven design in the field of protein therapeutics.

Guild

Series F in 2022
Guild's lifelong learning platform offers classes, programs, and degrees for working adults, with a path for them to move forward in their education and careers. It offers these adults support from start to finish, with their technology platform for discovery, learning, and organizing the experience, and extra support with their tech-enabled student advising model.

Flexport

Series E in 2022
Flexport, established in 2013, is a San Francisco-based company specializing in global freight forwarding and customs brokerage services. It offers an online platform that simplifies and streamlines international trade for businesses. Flexport's services include customs clearance, freight transportation by ocean, air, and road, along with value-added services such as cargo insurance, warehousing, and trade finance. The company's user-friendly dashboard enables clients to understand, purchase, manage, and track these services in real-time, optimizing their supply chain and logistics operations.

Monarch Money

Monarch Money is a subscription-based platform that provides a personal finance program to track expenses. The platform aims to help consumers plan and manage their financial lives and adds all the transactions, across all bank accounts and credit cards, into one list, and creates a budget to understand where the money is going.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.